Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

One Fraction Simulation-Free Treatment With CT-Guided Stereotactic Adaptive Radiotherapy for Patients With Oligometastatic and Primary Lung Tumors (ONE STOP)

NCT06236516 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT06236516
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06236516 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
One Fraction Simulation-Free Treatment With CT-Guided Stereotactic Adaptive Radiotherapy for Patients With Oligometastatic and Primary Lung Tumors (ONE STOP)
Lead sponsor
Washington University School of Medicine
Phase
Not applicable
Overall status
Completed
Start date
February 26, 2024
Completion date
August 5, 2025
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer, oligometastatic lung tumor